Skip to the page

Data / Form D filings / Pharmesol Inc.

Pharmesol Inc.: Form D filings

Pharmesol Inc., a biotechnology company in Coppell, TX, filed 2 Form D notices with the SEC between 2023 and 2025. The latest, on March 18, 2025, reports an offering of $1.3 million with nothing sold yet.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
412 CEDAR CREST DRIVE, Coppell, TX, 75019
Phone
(614) 440-7531
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1962684

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Mar 18, 2025New notice$1,300,000$0$1,300,0000Yet to occursec.gov
Jan 25, 2023New notice$300,000$160,000$140,0002Jan 10, 2023sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
SIYEON PARKExecutive Officer

Other biotechnology companies in Texas that filed recently

Every Form D from the week of Mar 17, 2025 · All recent filings in Texas · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Pharmesol Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.